These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 7851161)
1. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Steck K; el-Naggar AK Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161 [TBL] [Abstract][Full Text] [Related]
2. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Teague K; el-Naggar A Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study. Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728 [TBL] [Abstract][Full Text] [Related]
4. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content. Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238 [TBL] [Abstract][Full Text] [Related]
5. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction. Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315 [TBL] [Abstract][Full Text] [Related]
6. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306 [TBL] [Abstract][Full Text] [Related]
7. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry. Krauss JS; Pantazis CG; Chandler FW Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428 [TBL] [Abstract][Full Text] [Related]
8. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis. Cheville JC; Terrell RB; Cohen MB Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
11. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [TBL] [Abstract][Full Text] [Related]
12. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings. Serio G Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759 [TBL] [Abstract][Full Text] [Related]
13. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542 [TBL] [Abstract][Full Text] [Related]
14. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen. Yu CC; Dublin EA; Camplejohn RS; Levison DA Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754 [TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma]. Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706 [TBL] [Abstract][Full Text] [Related]
19. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions. Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of proliferative cells. Mokrý J; Nĕmecek S Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]